Pharmaniaga Bhd
KLSE:PHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
MY |
|
Roblox Corp
NYSE:RBLX
|
US |
|
Spok Holdings Inc
NASDAQ:SPOK
|
US |
|
Argan Inc
NYSE:AGX
|
US |
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
M
|
Millbank Mining Corp
XTSX:MILL
|
CA |
|
N
|
NextSource Materials Inc
OTC:NSRCF
|
CA |
|
St James's Place PLC
LSE:STJ
|
UK |
|
Alliance Entertainment Holding Corp
NASDAQ:AENT
|
US |
|
D-Box Technologies Inc
TSX:DBO
|
CA |
|
Cosmo Energy Holdings Co Ltd
TSE:5021
|
JP |
Wall St Price Targets
PHARMA Price Targets Summary
Pharmaniaga Bhd
According to Wall Street analysts, the average 1-year price target for PHARMA is 0.32 MYR with a low forecast of 0.2 MYR and a high forecast of 0.39 MYR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHARMA's stock price target?
Price Target
0.32
MYR
According to Wall Street analysts, the average 1-year price target for PHARMA is 0.32 MYR with a low forecast of 0.2 MYR and a high forecast of 0.39 MYR.
What is the Revenue forecast for Pharmaniaga Bhd?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Pharmaniaga Bhd?
Projected CAGR
27%
Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for Pharmaniaga Bhd?
Projected CAGR
59%
Over the last 14 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 59%.
